Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pharmacokinetic de-risking tools for selection of monoclonal antibody lead candidates
Miroslav Dostálek, Thomayant Prueksaritanont, Robert F. Kelley
mAbs (2017) Vol. 9, Iss. 5, pp. 756-766
Open Access | Times Cited: 40

Showing 1-25 of 40 citing articles:

Next generation antibody drugs: pursuit of the 'high-hanging fruit'
Paul J. Carter, Greg A. Lazar
Nature Reviews Drug Discovery (2017) Vol. 17, Iss. 3, pp. 197-223
Closed Access | Times Cited: 670
Structure, heterogeneity and developability assessment of therapeutic antibodies
Yingda Xu, Dongdong Wang, Bruce D. Mason, et al.
mAbs (2018) Vol. 11, Iss. 2, pp. 239-264
Open Access | Times Cited: 227
Tutorial on Monoclonal Antibody Pharmacokinetics and Its Considerations in Early Development
Meric Ovacik, Kedan Lin
Clinical and Translational Science (2018) Vol. 11, Iss. 6, pp. 540-552
Open Access | Times Cited: 219
Understanding and overcoming trade-offs between antibody affinity, specificity, stability and solubility
Lilia A. Rabia, Alec A. Desai, Harkamal S. Jhajj, et al.
Biochemical Engineering Journal (2018) Vol. 137, pp. 365-374
Open Access | Times Cited: 123
Establishing in vitro in vivo correlations to screen monoclonal antibodies for physicochemical properties related to favorable human pharmacokinetics
Lindsay B. Avery, Jason Wade, Mengmeng Wang, et al.
mAbs (2017) Vol. 10, Iss. 2, pp. 244-255
Open Access | Times Cited: 90
Non-specificity as the sticky problem in therapeutic antibody development
Hannes Ausserwöger, Matthias M. Schneider, Therese W. Herling, et al.
Nature Reviews Chemistry (2022) Vol. 6, Iss. 12, pp. 844-861
Closed Access | Times Cited: 53
Toward Drug-Like Multispecific Antibodies by Design
Manali Sawant, Craig Streu, Lina Wu, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 20, pp. 7496-7496
Open Access | Times Cited: 52
Surface patches induce nonspecific binding and phase separation of antibodies
Hannes Ausserwöger, Georg Krainer, Timothy J. Welsh, et al.
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 15
Open Access | Times Cited: 13
Physiologically Based Pharmacokinetic Modeling to Characterize the Effect of Molecular Charge on Whole-Body Disposition of Monoclonal Antibodies
Shufang Liu, Dhaval K. Shah
The AAPS Journal (2023) Vol. 25, Iss. 3
Closed Access | Times Cited: 13
Engineering a bispecific antibody with a common light chain: Identification and optimization of an anti-CD3 epsilon and anti-GPC3 bispecific antibody, ERY974
Hirotake Shiraiwa, Atsushi Narita, Mika Kamata‐Sakurai, et al.
Methods (2018) Vol. 154, pp. 10-20
Closed Access | Times Cited: 43
Allometric scaling of therapeutic monoclonal antibodies in preclinical and clinical settings
Eva Germovsek, Ming Cheng, Craig Giragossian
mAbs (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 31
“Assessing Impact of Hinge Flexibility on Predicted Second Osmotic Virial Coefficients”
Terrance Shoemaker, Brendan R. Amer, Vladimir I. Razinkov, et al.
European Journal of Pharmaceutical Sciences (2025), pp. 107064-107064
Open Access
Isoelectric point, net charge and amino acid analysis of experimentally validated therapeutic antibodies
Anil Kumar Nagraj, Riya Patel, Akshata S. Gavade, et al.
In Silico Pharmacology (2025) Vol. 13, Iss. 2
Closed Access
Assessment and incorporation of in vitro correlates to pharmacokinetic outcomes in antibody developability workflows
Tushar Jain, Bianka Prinz, Alexander Marker, et al.
mAbs (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 3
Novel in Vivo and in Vitro Pharmacokinetic/Pharmacodynamic-Based Human Starting Dose Selection for Glofitamab
Nicolas Frances, Marina Bacac, Katharine Bray‐French, et al.
Journal of Pharmaceutical Sciences (2021) Vol. 111, Iss. 4, pp. 1208-1218
Closed Access | Times Cited: 18
Improved antibody pharmacokinetics by disruption of contiguous positive surface potential and charge reduction using alternate human framework
Romain Ollier, Aline Fuchs, Florence Gauye, et al.
mAbs (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 7
Characterizing the Pharmacokinetics and Biodistribution of Therapeutic Proteins: An Industry White Paper
Kathryn Ball, Gerard Bruin, Enrique Escandón, et al.
Drug Metabolism and Disposition (2022) Vol. 50, Iss. 6, pp. 858-866
Open Access | Times Cited: 12
Insight into the avidity–affinity relationship of the bivalent, pH-dependent interaction between IgG and FcRn
Johannes Reusch, Jan Terje Andersen, Ulrich Rant, et al.
mAbs (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 2
Toward a Combinatorial Approach for the Prediction of IgG Half-Life and Clearance
Dennis R. Goulet, Michael J. Watson, Susan H. Tam, et al.
Drug Metabolism and Disposition (2018) Vol. 46, Iss. 12, pp. 1900-1907
Open Access | Times Cited: 17
Harnessing the Therapeutic Potential of ‘Rogue’ Antibodies
Jordan D. Dimitrov
Trends in Pharmacological Sciences (2020) Vol. 41, Iss. 6, pp. 409-417
Open Access | Times Cited: 14
Functional humanization of immunoglobulin heavy constant gamma 1 Fc domain human FCGRT transgenic mice
Benjamin E. Low, Gregory J. Christianson, Emily Lowell, et al.
mAbs (2020) Vol. 12, Iss. 1
Open Access | Times Cited: 13
Microphysiological endothelial models to characterize subcutaneous drug absorption
Giovanni S. Offeddu
ALTEX (2022)
Open Access | Times Cited: 8
Non-human primates in the PKPD evaluation of biologics: Needs and options to reduce, refine, and replace. A BioSafe White Paper
Karelle Ménochet, Hongbin Yu, Bonnie Wang, et al.
mAbs (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 8
Embedding Dynamics in Intrinsic Physicochemical Profiles of Market-Stage Antibody-Based Biotherapeutics
Giuseppe Licari, Kyle P. Martin, Maureen Crames, et al.
Molecular Pharmaceutics (2022) Vol. 20, Iss. 2, pp. 1096-1111
Open Access | Times Cited: 8
Monoclonal Antibodies: From Structure to Therapeutic Application
Rong Deng, Junyi Li, C. Andrew Boswell, et al.
Pharmaceutical biotechnology (2024), pp. 165-207
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top